Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations
   

EFPIA Newsletter 4 November 2021

 
 
 
   

AMR: Let's find the solutions

Superbugs could set medicine back to the 19th century, before the discovery of penicillin, when simple infections could kill. How can we ensure there is a sustainable pipeline of new antimicrobials?


 
 
 
 
   

Blogs

 

Lung Cancer Awareness Month: The importance of the patient perspective in driving advancements...
02 November 2021 - Catherine Taylor

Reducing the burden of lung cancer and transforming long-term outcomes for patients Read more

What does it take to get the world vaccinated against COVID-19?
29 October 2021 - Sibilia Quilici - Koen Berden

The real path to global vaccine equity Read more

 
 
 
   

Making the impossible, possible

 

IFPMA
Science, collaboration and innovation made it possible to have several COVID-19 vaccines in one year and #WeWontRest... Read more

Vaccines Europe
Using mRNA technology to develop vaccines was once impossible, but thanks to 40 years of research it's now possible.... Read more

 
 
 
   

Events

 

Investigating the syndemic threat of COVID-19 and chronic disease: The diabetes case
09 November 2021 (Virtual event)

Improved integration of care is the way forward to strengthen chronic disease management in emergencies and beyond Read more

Joint EFPIA & EFGCP “Good Lay Summary Practice” Recommendations
09 November 2021 (Virtual event)

The new tool you should use to comply with the European Clinical Trial Regulation (EU No. 536/2014) Read more

Pandemic Prevention: how Europe can lead the fight against AMR
16 November 2021 (Virtual event)

The COVID-19 pandemic took the world by surprise. An AMR induced pandemic will not. Read more

DIA Europe 2022
29 March 2022 (Hybrid conference (virtual - Brussels))

Advancing Health Priorities Read more

 
 
 
   

COP26: How pharmaceutical companies are helping the fight against climate change

Find out what our companies are working on.

 
 
 
 
   

What we are reading

 

Pharma Companies Launch Supplier Program to Advance Climate Action
On 04 November 2021 (Schneider Electric)

Collaboration aims to accelerate the adoption of renewable energy and reduce greenhouse gas emissions within the pharmaceutical... Read more

New European initiative will build a collaborative platform for data and sample sharing, to accelerate...
On 02 November 2021 (Alzheimer Europe)

EPND is a public-private partnership funded by IMI Read more

Unlocking the potential of mRNA to inform the treatments and vaccines of tomorrow
On 26 October 2021 (STAT)

By Uwe Schoenbeck, PhD, SVP & chief scientific officer, Emerging Science & Innovation, Pfizer Read more